ITOC2 – 029. Combination of CTLA4-blockade, depletion of CD25+ cells and active-specific immunotherapy prolongs survival in murine melanoma
Author:
Kovács R. Julia,Rose Peter,Boon Louis,Hatz A. Rudolf,Winter Hauke,Van Den Engel K. Natasja
Publication:
European Journal of Cancer